Diabetes mellitus (DM) is a chronic hyperglycemic condition due to metabolic derangements mainly attributed to absolute insulin deficiency or defect in insulin action.
INTRODUCTION
Diabetes mellitus (DM) is a chronic hyperglycemic condition due to metabolic derangements mainly attributed to absolute insulin deficiency or defect in insulin action.
1, 2
Almost 6% of world's population are affected by DM and the burden is increasing at an alarming rate.
2 Nepal is also facing the increase burden of DM as like other nations globally. 2 It is assumed that one in ten Nepalese have DM and the prevalence is higherin compare to India, Pakistan and Bangladesh. [3] [4] [5] [6] Studies from Nepal further indicates that about 50% of the cases of DM remain undiagnosed.
5
Compounded by lack of quality health service, lack of routine health checkup, personal ignorance, and late consultation to health care provider, the complications of DM might be higher or more severe in our setting. 
Prevalence of peripheral neuropathy in diabetes mellitus and its association with therapy, ethnicity and duration of diabetes mellitus
Diabetes mellitus poses significant morbidity and mortality if untreated because of its associated late complications in the form of microvascular and macro-vascular structures.
1 Complications are imputed to hyperglycemia, non-enzymatic glycation, oxidative stress, dyslipidemia, increased polyol pathway activity, altered perfusion, etc. that are seen in diabetic patients.
1 Development of diabetic complications and its severity is correlated to length of DM.
5 Furthermore, people with type-2 DM are at high risk of complications due to its insidious nature and late diagnosis, than type -1 DM.
2
Neuropathy has been considered as important micro vascular complication of diabetes and sometimes reasoned as the pathological process for other abnormalities in DM. 1, 7, 8 Neuropathy is present from early stage of DM which slowly progresses over several years causing systemic damage.
1
Diabetic wound classification system proposes that the risk of amputation increases by 1.7 times in case of diabetic neuropathy.
7,9 Foot ulcers, charcots joints, numbness, paresthesia, loss of coordination, burning, pricking pain, abnormal ankle reflexes, etc. are manifestations of neuropathy.
1 Studies shows about 50 -90% of diabetics sooner or later develop one or other types of neuropathy.
1, 10
The prevalence of diabetic neuropathy ranges from 9.6% to 78% in different populations making it the most frequent chronic complications of DM. 1, 11, 12 Study from Nepal has also reported the high prevalence of diabetic neuropathy correlating with older age and long duration DM to be significant risk factors.
10, 13, 14
About 60-70% of foot ulcer that appear in diabetic patients are primarily neuropathic in origin. 12 The vicious cycle which involves chronic hyperglycemia, spontaneous glycation of proteins, defect in nerves, metabolic derangements, alterations of micro-vessels, hypoxia, ischemia, inflammation, etc. are implicated in developing neuropathy.
1, 11 Development of neuropathy and its severity increases with increase in duration of DM and poor glycemic control 7 ; a study shows, there is 49% chance of getting neuropathy with 25 years old diabetic history. 5, 15 Similarly in another study, strict glycemic control by intensive therapy was found to significantly reduce microvascular complications like neuropathy but the findings are still contradictory. 7 Many studies have found ethnic variation in diabetic neuropathy. A study done in U.K reports lower incidence of neuropathy in Asians than White population, but the outcomes are disparate with no explanations. 16 However, studies variably indicates that older age, gender, duration of DM, dyslipidemia, ethnicity are associated with diabetic neuropathy, so, much in depth studies are needed to explore the reasonable explanation.
12
Since diabetes has higher prevalence in South Asian region with poor and low income countries experiencing huge burden. 17 Thus, it is logical to speculate high rate of diabetic complications like neuropathy, in people living in these areas.
Neuropathy is most common complication of DM which starts subtly. A better understanding of this progressive condition is essential for better prognosis.
1 Early identification and suitable management of neuropathy in diabetic subjects is essential for many reasons: 1) many therapeutic options are available for symptomatic patients; 2) about 50% of neuropathy can be asymptomatic and patient are at risk of insensate foot injury; 3) reduce the foot ulceration and amputation. 5 Nepal is low income country in south Asian region and thus lies in high prevalence zone for diabetes, and thus, likely to have many diabetic people with neuropathies and other chronic complications. Limited studies have been done about chronic diabetic complications like neuropathy, which necessitates the requirement of further research in our setting to make nationwide database. Moreover, there was no published data to evaluate DPN by using the biothesiometry. Therefore, in this study we have made effort to find the prevalence of diabetic neuropathy using biothesiometry. Furthermore, we investigated the association of DPN with ethnicity, duration of DM and diabetic therapy.
MATERIALS AND METHODS
This is a Hospital based cross-sectional study conducted in Fishtail Hospital and Research Center Pvt. Ltd. One hundred and ten clinically diagnosed diabetic patients attending the Department of Internal Medicine, Fishtail Hospital& Research Center, who were under anti-diabetic therapy, were enrolled. Ethnical Clearance was sought from the Research Committee of Fishtail Hospital& Research Center and verbal consent was taken from all the study subjects during clinical examination.
Detailed history and clinical examinations were carried out in enrolled subjects. They were then subjected to neuropathy screening using biothesiometry which is sensitive method to detect and evaluate peripheral neuropathy with impaired vibratory perception threshold (VPT), mainly in diabetology and neurology. Its principle is vibrating probe, where amplitude of vibration can be altered by adjustment of voltage. 
RESULT
One hundred and ten diabetic patients were studied for the presence of diabetic peripheral neuropathy (DPN). The overall basic and clinical characteristics of study subjects are shown in Table 1 .
There were 45 female (41%) and 65 male (59%) with the mean age of 54.55±12.52 years ranging from 30 to 92 years; most of the patients were more than in their fifties. The overall prevalence of DPN was found to be 45.45%. In male the prevalence of DNP was 47.7% whereas the prevalence rate in female was 42.2%. In both gender mild neuropathy was most common complaint and severe form was present in only 4.5% of the patients. However, more than half of the diabetic patients i.e. 60 (54.5%) had no symptoms neuropathy. The association between gender and neuropathy was not significant (p=0.22)
As shown in figure 1 , the prevalence of DPN was higher with increase in age, from 23.5% in ≤40 years age group; 36.7% in age group 41-60 years and 72.7% in >60 years age group, Furthermore, the severe neuropathy was also present in older age. Presence of neuropathy with increasing age was highly significant (p=0.007). Similarly, comparison between ethnicity showed more Brahmins with neuropathy than other ethnic groups, however, the ethnic variation was not significant (p=0.12)
In the meantime, the association between DPN and duration was DM was highly significant (p=0.004) as shown in figure 2 . The rate of DPN was higher with increase in duration of DM, 31.0% in <5 years, 58.8% in 5-10 years and 66.6% in >10 years with severe neuropathy seen above 5 years (4.5%) of DM. All the patients were under medication, either monotherapy or polytherapy. However, neuropathy was present in these patients with 52.1% under polytherapy and 40.6% under monotheraphy had DPN, but majority of patients (54.5%) under medication had normal finding. Although, this was found to be insignificant (p=0.32).
DISCUSSION
The prevalence of DPN in our study was found to be 45.45% with male and female equally affected which is comparable with study done by Yogi et al. 1 and Dyck et al.
8 which has reported the prevalence of 48% and 47% respectively.
1 The study done by Karki et al. 13 in Kathmandu Medical College has reported higher prevalence rate of 58.7% and similarly a European study 19 also reported overall DPN prevalence of 60% which was higher than our study. However, several other studies done in different places has reported low prevalence rate of DPN in DM (19.7%, 20 19.1%,
21
). In our study there was no significant difference in DPN between male and female which is in accordance with other studies. 13, 22 Although studies have reported conflicting results, the effect of gender on neuropathy remains elusive.
23
Study from Nepal reported the high prevalence of diabetic neuropathy ranging from 22.2% to 58.7% in different regions, 10, 13, 14 correlating with older age and long duration of DM to be significant risk factors for neuropathy 13 , similarly, another study showed the prevalence of 44.4%.
10
There was highly significant difference in prevalence DPN in different age groups and duration of DM; DPN was more prevalent with increase in age and long duration of DM. In accordance with our findings numerous studies has shown that increasing age and long standing DM are significant risk factors of DPN in DM. 7, 13, 21 Although not significant in this study, therapy did not significantly reduce the burden neuropathy which is in accordance with other literatures. 23, 24 However, it is widely agreed that controlling hyperglycemia is the only option to reduce the onset and progression of neuropathy while no treatment options are available. 7 A study reasons that frequency of occurrence of neuropathy in DM patients under therapy depend on type of DM, duration of treatment and duration of DM.
23

LIMITATIONS OF THE STUDY
Only biothesiometry was used and it could not be compared with nerve conduction study which is a gold standard for diagnosing peripheral neuropathy. In addition, we were unable to rule out other confounding factors which could affect the results.
CONCLUSION
Peripheral Neuropathy was measured by using biothesiometry which is based on assessment of Vibratory perception threshold measurement. It is easy, cheap and precise tool for detecting peripheral neuropathy and widely used by clinicians in diabetology or neurology practice. It can even be used in field studies for screening purpose. Chronic DM is commonly associated with DPN which is evident from our study with high prevalence rate of 45.45%. Further, the prevalence rate increased with duration of DM and increasing age. In addition, although intensive therapy to control hyperglycemia can reduce incidence of DPN. However, in this study the prevalence of DPN in DM patients was not significantly different among monotherapy or polytherapy groups. 
